RYTM - Rhythm Pharmaceuticals Inc. (RYTM) CEO David Meeker on Q2 2021 Results - Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. (RYTM) Q2 2021 Results Earnings Conference Call August 3, 2021, 08:00 AM ET Company Participants David Connolly - Head of Investor Relations and Corporate Communications David Meeker - Chairman, President and Chief Executive Officer Murray Stewart - Chief Medical Officer Jennifer Chien - Executive Vice President, Head of North America Yann Mazabraud - Executive Vice President, Head of International Hunter Smith - Chief Financial Officer Conference Call Participants Phil Nadeau - Cowen and Company Avatar Jones - Morgan Stanley Tazeen Ahmad - Bank of America Merrill Lynch Joseph Stringer - Needham & Company Graig Suvannavejh - Goldman Sachs Presentation Operator Good day and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Q2 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. I would now like to hand the

For further details see:

Rhythm Pharmaceuticals, Inc. (RYTM) CEO David Meeker on Q2 2021 Results - Earnings Call Transcript